Health-care companies rose amid deal activity and demand for sectors less sensitive to inflation rates.
Health-care companies rose amid deal activity and demand for sectors less sensitive to inflation rates.
CVC Capital Partners and Groupe Bruxelles Lambert joined forces for an offer to take Recordati private with a bid that values the Italian drugmaker at $12.47 billion.
Novo Nordisk rose after the European Medicines Agency recommended the approval of the Danish company's Wegovy weight-loss pill.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
CVC consortium tables $12.4bn bid to delist Italian drugmaker Recordati - Pharmaceutical Technology
GHO Capital, CBC Group plan to merge, forming $21B healthcare investment firm
I fondi CVC e GBL lanciano l’opa su Recordati: delisting dopo 40 anni e una performance del 10.240% | MilanoFinanza News
Consórcio CVC lança oferta de 10,9 bilhões de euros pela farmacêutica italiana Recordati
Freestanding EDs, urgent care acquisition opportunities abound for HCA Healthcare
Investment giants join forces to form largest healthcare firm on the globe - Pharmaceutical Technology
CVC e GBL lançam oferta de 10,7 bi de euros para fechar o capital da farmacêutica Recordati
Wall Street Analysts Are Bullish on Top Healthcare Picks
